Lymphedema: Pathogenesis, prevention, and treatment

Cancer Practice

Volumn 5, Issue 1, 1997, Pages 32-38

  Marcks, Patrice ^a,b  

^a White Memorial Medical Center   (United States)

^b NONE   (United States)

Author keywords

axillary node dissection; breast cancer; lymphedema; Orem's theory; quality of life

Indexed keywords

ANTIBIOTIC AGENT; COUMARIN;

BREAST CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; QUALITY OF LIFE; REVIEW;

HUMANS; INCIDENCE; LYMPHEDEMA; PRIMARY PREVENTION; QUALITY OF LIFE; RISK FACTORS;

EID: 0031039257     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Cancer Facts and Figures-1996. Atlanta, GA: The American Cancer Society; 1996.
2. Markowski J, Wilcox J, Helm P. Lymphedema incidence after specific postmastectomy therapy. Arch Phys Med Rehabil 1981; 62:449-452.
3. Brennan M. Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage 1992; 7:110-116.
4. Kumar V, Cotran R, Robbins S. Basic Pathology. 5th ed. Philadelphia, PA: WB Saunders Co; 1992:299-300.
5. Benenson A. Filariasis. In: Benenson A, ed. Control of Communicable Diseases in Man. 16th ed. Washington, DC: American Public Health Association; 1995:178-183.
6. Kisson M, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73:580-584.
7. Aitken D, Minton J. Complications associated with mastectomy. Surg Clin North Am 1983; 63:1331-1352.
8. Gerber L, Levinson S, Hicks J, et al. Evaluation and management of disability: rehabilitation aspects of cancer. In: DeVita V, Hellman S, Rosenberg S, eds. Cancer: Principles and Practice of Oncology: 4th ed. Philadelphia, PA: Lippincott; 1993:2549.
9. Berne R, Levy M. Principles of Physiology. 2nd ed. St. Louis, MO: Mosby; 1996:310.